Publications by authors named "Kadri Altundag"

590 Publications

Specific Histological Subgroups in Invasive Lobular Carcinoma Might Affect Management Strategy in Invasive Lobular Carcinoma of the Breast.

Authors:
Kadri Altundag

Ann Surg Oncol 2021 May 13. Epub 2021 May 13.

Tepe Prime, MKA Breast Cancer Clinic, 06800, Ankara, Turkey.

View Article and Find Full Text PDF

Download full-text PDF

Source
http://dx.doi.org/10.1245/s10434-021-10119-6DOI Listing
May 2021

Is there any association between a delay in surgery and nodal positivity in the ER-negative Her2 negative breast cancer subgroups?

Authors:
Kadri Altundag

J Surg Oncol 2021 Apr 12. Epub 2021 Apr 12.

MKA Breast Cancer Clinic, Ankara, Turkey.

View Article and Find Full Text PDF

Download full-text PDF

Source
http://dx.doi.org/10.1002/jso.26485DOI Listing
April 2021

Breast cancer subtypes in transplant patients: Does it really matter?

Authors:
Kadri Altundag

Clin Imaging 2021 Mar 23;78:93. Epub 2021 Mar 23.

MKA Breast Cancer Clinic, Tepe Prime, Cankaya, 06800, Ankara, Turkey. Electronic address:

View Article and Find Full Text PDF

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.clinimag.2021.02.042DOI Listing
March 2021

Do all triple-negative breast cancer patients have to receive adjuvant chemotherapy within 30 days after surgery; do subtypes matter?

Authors:
Kadri Altundag

J BUON 2021 Jan-Feb;26(1):283

MKA Breast Cancer Clinic, Tepe Prime, Cankaya, 06800 Ankara, Turkey.

View Article and Find Full Text PDF

Download full-text PDF

Source
March 2021

Is up-front surgery associated with fatality of disease in breast cancer patients with de novo metastases?

Authors:
Kadri Altundag

J BUON 2021 Jan-Feb;26(1):282-283

MKA Breast Cancer Clinic, Tepe Prime, Cankaya, 06800 Ankara, Turkey.

View Article and Find Full Text PDF

Download full-text PDF

Source
March 2021

Do molecular subtypes affect overall survival after radiation therapy for breast cancer patients with brain metastases?

Authors:
Kadri Altundag

J BUON 2021 Jan-Feb;26(1):281

MKA Breast Cancer Clinic, Tepe Prime, Cankaya, 06800 Ankara, Turkey.

View Article and Find Full Text PDF

Download full-text PDF

Source
March 2021

Association between nanobacteria and microcalcifications in breast.

Authors:
Kadri Altundag

J BUON 2021 Jan-Feb;26(1):280-281

MKA Breast Cancer Clinic, Tepe Prime, Cankaya, 06800 Ankara, Turkey.

View Article and Find Full Text PDF

Download full-text PDF

Source
March 2021

The impact of time to surgery in different tumor subtypes in breast cancer patients who received neoadjuvant chemotherapy.

Authors:
Kadri Altundag

J BUON 2021 Jan-Feb;26(1):280

MKA Breast Cancer Clinic, Tepe Prime, Cankaya, 06800 Ankara, Turkey.

View Article and Find Full Text PDF

Download full-text PDF

Source
March 2021

A closer look at pulmonary carcinoid in a large breast cancer dataset.

Authors:
Kadri Altundag

J BUON 2021 Jan-Feb;26(1):279

MKA Breast Cancer Clinic, Tepe Prime, Cankaya, 06800 Ankara, Turkey.

View Article and Find Full Text PDF

Download full-text PDF

Source
March 2021

The impact of efficacy of receptor conversion on metastases directed therapies in liver metastases with breast cancer.

Authors:
Kadri Altundag

J BUON 2021 Jan-Feb;26(1):278

MKA Breast Cancer Clinic, Tepe Prime, Cankaya, 06800 Ankara, Turkey.

View Article and Find Full Text PDF

Download full-text PDF

Source
March 2021

A positive conversion in Hormone Receptor and HER2 status and other metastatic sites might have a impact on survival for breast cancer patients with ovarian metastases.

Authors:
Kadri Altundag

J Gynecol Obstet Hum Reprod 2021 Apr 13;50(4):102090. Epub 2021 Feb 13.

MKA Breast Cancer Clinic, Tepe Prime, Cankaya, 06800, Ankara, Turkey. Electronic address:

View Article and Find Full Text PDF

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jogoh.2021.102090DOI Listing
April 2021

Efficacy and safety evaluation of eribulin-trastuzumab combination therapy with heavily pretreated HER2-positive metastatic breast cancer.

J BUON 2020 Nov-Dec;25(6):2562-2569

Istinye University Faculty of Medicine, Department of Medical Oncology, Ankara, Turkey.

Purpose: Eribulin mesylate is a non-taxane microtubule inhibitor which is a synthetic holichondrin B analog that can be used after anthracycline and taxane treatment in patients with metastatic breast cancer. We aimed to analyze the results of eribulin-trastuzumab combination in aggressively pretreated metastatic HER2-positive breast cancer patients.

Methods: In this single-center study, the records of 36 patients with HER-2-positive metastatic breast cancer who received at least one cycle of eribulin-trastuzumab in our clinic between 2015 and 2018 were analyzed retrospectively. Kaplan-Meier survival analysis was used for progression-free survival (PFS), and overall survival (OS) analyzes. Two-sided p values <0.05 were considered statistically significant.

Results: A total of 36 patients with metastatic breast cancer were eligible and included in this study. The median age of the patients was 41 years (range 20-60). Most patients were heavily pretreated with a median of 5 (range 3-8) previous chemotherapy lines before eribulin. At the end of the follow up period (February 2018) all patients received a median of 5.5 cycles of eribulin-trastuzumab. Partial response (PR) was achieved in 9 patients (25%) and stable disease (SD) in 17 patients (47%). Median PFS was 4 months (95% CI: 3.8-6.1), and median OS was 10 months (95% CI: 7.5-12.4). The most common adverse events were grade 1-2 anemia (n=12, 33%), neutropenia (n=12, 33%) and grade 3-4 neuropathy (n=4, 11.1%).

Conclusion: Eribulin-trastuzumab combination is an effective and safe treatment option with a low toxicity profile for aggressively pre-treated patients with metastatic breast cancer.
View Article and Find Full Text PDF

Download full-text PDF

Source
January 2021

Is there any association between conversion rates of HER2 status and metastatic sites in breast cancer patients?

Authors:
Kadri Altundag

J BUON 2020 Sep-Oct;25(5):2531

MKA Breast Cancer Clinic, Tepe Prime, Cankaya, 06800 Ankara, Turkey.

View Article and Find Full Text PDF

Download full-text PDF

Source
December 2020

Physiotherapists should be included in multidisciplinary team treating breast cancer patients with axillary lymph nodes dissection.

J BUON 2020 Sep-Oct;25(5):2531

Private Lymphedema Clinic, Ankara, Turkey.

View Article and Find Full Text PDF

Download full-text PDF

Source
December 2020

Association between common risk factors and molecular subtypes of breast cancer: Still debatable issue?

Authors:
Kadri Altundag

J BUON 2020 Sep-Oct;25(5):2530

MKA Breast Cancer Clinic, Tepe Prime, Cankaya, 06800 Ankara, Turkey.

View Article and Find Full Text PDF

Download full-text PDF

Source
December 2020

COVID-19 pandemic and some observations about management of breast cancer at private practice.

Authors:
Kadri Altundag

J BUON 2020 Sep-Oct;25(5):2530

MKA Breast Cancer Clinic, Tepe Prime, Cankaya, 06800 Ankara, Turkey.

View Article and Find Full Text PDF

Download full-text PDF

Source
December 2020

T1b with ER negative, HER2-positive, and node-negative breast cancer patients might get benefit from adjuvant chemotherapy.

Authors:
Kadri Altundag

J BUON 2020 Sep-Oct;25(5):2529

MKA Breast Cancer Clinic, Tepe Prime, Cankaya, 06800 Ankara, Turkey.

View Article and Find Full Text PDF

Download full-text PDF

Source
December 2020

Should estrogen receptor positive and progesterone receptor negative and HER-2 negative breast cancer patients be considered as a luminal B subtype?

Authors:
Kadri Altundag

J BUON 2020 Sep-Oct;25(5):2529

MKA Breast Cancer Clinic, Tepe Prime, Cankaya, 06800 Ankara, Turkey.

View Article and Find Full Text PDF

Download full-text PDF

Source
December 2020

Machine learning, AI, and breast cancer: A rallying call to drive adoption.

J BUON 2020 Sep-Oct;25(5):2528

MKA Breast Cancer Clinic, Ankara, Turkey.

View Article and Find Full Text PDF

Download full-text PDF

Source
December 2020

Chimeric antigen receptor macrophages for breast cancer: An emerging treatment modality.

J BUON 2020 Sep-Oct;25(5):2528

MKA Breast Cancer Clinic, Ankara, Turkey.

View Article and Find Full Text PDF

Download full-text PDF

Source
December 2020

Effect of a switch of aromatase inhibitors to another aromatase inhibitor or tamoxifen on musculoskeletal symptoms in breast cancer; Which is the best?

Authors:
Kadri Altundag

J BUON 2020 Jul-Aug;25(4):2132

MKA Breast Cancer Clinic, Tepe Prime, Cankaya, 06800 Ankara, Turkey.

View Article and Find Full Text PDF

Download full-text PDF

Source
October 2020

Behcet's disease and breast cancer.

Authors:
Kadri Altundag

J BUON 2020 Jul-Aug;25(4):2129-2130

MKA Breast Cancer Clinic, Tepe Prime, Cankaya, 06800 Ankara, Turkey.

View Article and Find Full Text PDF

Download full-text PDF

Source
October 2020

Luminal subtypes and response to neoadjuvant chemotherapy for hormone receptor-positive HER2-negative patients.

Authors:
Kadri Altundag

Breast Cancer Res Treat 2020 12 4;184(3):999. Epub 2020 Sep 4.

MKA Breast Cancer Clinic, Tepe Prime, Cankaya, 06800, Ankara, Turkey.

View Article and Find Full Text PDF

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10549-020-05883-0DOI Listing
December 2020

Clinical and pathological characteristics of breast cancer patients with sarcoidosis.

Authors:
Kadri Altundag

J BUON 2020 May-Jun;25(3):1669

MKA Breast Cancer Clinic, Tepe Prime, Ankara, Turkey.

View Article and Find Full Text PDF

Download full-text PDF

Source
August 2020

Specific histological subgroups in invasive lobular carcinoma might affect outcome in both chemotherapy and non-chemotherapy groups.

Authors:
Kadri Altundag

J BUON 2020 May-Jun;25(3):1667

MKA Breast Cancer Clinic, Tepe Prime, Ankara, Turkey.

View Article and Find Full Text PDF

Download full-text PDF

Source
August 2020

Is there a role of anthracycline use in the management of de novo HER-2 positive metastatic breast cancer?

Authors:
Kadri Altundag

J BUON 2020 May-Jun;25(3):1667

MKA Breast Cancer Clinic, Tepe Prime, Ankara, Turkey.

View Article and Find Full Text PDF

Download full-text PDF

Source
August 2020

Sentinel lymph node biopsy in papillary breast cancer; to do or not to do?

Authors:
Kadri Altundag

J BUON 2020 May-Jun;25(3):1666

MKA Breast Cancer Clinic, Tepe Prime, Ankara, Turkey.

View Article and Find Full Text PDF

Download full-text PDF

Source
August 2020

Poor histological subtype and response to neoaadjuvant treatment in triple-negative breast cancer.

Authors:
Kadri Altundag

J BUON 2020 May-Jun;25(3):1665

MKA Breast Cancer Clinic, Tepe Prime, Ankara, Turkey.

View Article and Find Full Text PDF

Download full-text PDF

Source
August 2020